Search results

Multi-million dollar Australian Cancer Research Foundation (ACRF) Detector launched at the Australian Synchrotron,

Australian researchers and clinicians have recently returned from Japan where they investigated the use of advanced radiation therapy for cancer using heavy ions at particle therapy facilities on a study tour .

Nuclear security experts and officials from Australia’s nuclear agencies have convened at the International Atomic Energy Agency’s (IAEA) headquarters in Vienna, Austria last week for the International Conference on Nuclear Security (ICONS).

Read about an ANSTO scientist and their work to prepare for a school project or interview.

Researchers from the University of New South Wales have developed a new type of rechargeable battery that uses protons as charge carriers, offering a safer and more environmentally friendly alternative to conventional lithium-ion batteries.

Professor of Soil Science at The University of Queensland, Peter Kopittke and partner investigator Prof Enzo Lombi of the University of SA are very optimistic about the use of a new synchrotron-based imaging technique that captures in 3D the complex interaction of soil and root.

ANSTO is a unique national science organisation that began operating under its predecessor The Australian Atomic Energy Commission (AAEC) 70 years ago.

The Imaging and Medical beamline (IMBL) is a flagship beamline of the Australian Synchrotron built with considerable support from the NHMRC. It is one of only a few of its type, and delivers the world’s widest synchrotron x-ray ‘beam’.

The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.

Think Science! 2023 Summary and Results

The User Advisory Committee (UAC) are pleased to present this year's invited speakers.

ANSTO User Meeting 2021 - Speakers

Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.

Doping with transition metals produced stability in bismuth oxide.

Doping with transition metals produced stability in bismuth oxide.